| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $387,093 ) |
| | 2025 | 2025 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | K22CA279495 | Elucidating Mechanisms of CAR ML NK cell biology to treat cancer and infection | 000 | 2 | NIH | 12/18/2024 | $186,030 |
| | 2025 | 2025 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | F30DK134124 | Defining Inflammatory Triggers that Induce Diverse Subtypes of Gastric Metaplasia | 000 | 3 | NIH | 12/6/2024 | $53,974 |
| | 2025 | 2025 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01DK132162 | Determining hepatocyte-specific mechanisms by which Ube4A regulates NAFLD/NASH | 000 | 3 | NIH | 12/17/2024 | $462,823 |
| | 2025 | 2025 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01DK134531 | The Role of Inflammation in Regulating Gastric Metaplasia | 000 | 3 | NIH | 12/12/2024 | $484,531 |
| | 2025 | 2025 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R35GM152125 | Methods and technologies for chemical synthesis of glycans | 001 | 2 | NIH | 12/5/2024 | $334,821 |
| | 2025 | 2025 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R21AG089917 | Cathepsin-L mediated remodeling of the nuclear proteome | 000 | 1 | NIH | 11/13/2024 | $227,250 |
| | 2025 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | S10OD036230 | High Q Technologies FATHOM Pulse EPR Spectrometer | 001 | 1 | NIH | 11/27/2024 | $0 |
| | 2025 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | S10OD036230 | High Q Technologies FATHOM Pulse EPR Spectrometer | 001 | 1 | NIH | 11/27/2024 | $0 |
| | 2025 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | S10OD036230 | High Q Technologies FATHOM Pulse EPR Spectrometer | 000 | 1 | NIH | 11/19/2024 | -$146,530 |
| | 2025 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R35GM152125 | Methods and technologies for chemical synthesis of glycans | 000 | 1 | NIH | 11/5/2024 | $0 |
| | 2025 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R35GM149320 | Coordination of DNA Metabolism by Replication Protein A | 000 | 2 | NIH | 11/5/2024 | $0 |
| | 2025 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R21CA263428 | Pre-clinical testing the effects of MALT1 inhibitor on endocrine resistant breast cancer | 000 | 2 | NIH | 1/3/2025 | $0 |
| | 2025 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01CA238705 | Defining how obesity shapes immunity and the success of cancer immunotherapy | 000 | 5 | NIH | 12/4/2024 | -$5,560 |
| | 2025 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01DK118340 | Integrative Physiology of Obesity: Role of GPR160 | 000 | 5 | NIH | 12/4/2024 | $0 |
| | 2025 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | UH3HD096929 | Innovative Tools to Expand Youth-Friendly HIV Self-Testing (I-TEST) | 000 | 5 | NIH | 12/3/2024 | -$729,628 |
| | 2025 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | UH3HD096929 | Innovative Tools to Expand Youth-Friendly HIV Self-Testing (I-TEST) | 001 | 4 | NIH | 12/3/2024 | -$134,672 |
| | 2025 | 2021 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R21NR017978 | The Social Context of Live Discharge from Hospice for Family Caregivers of Patients with Alzheimer's Disease and Related Dementias | 000 | 2 | NIH | 11/26/2024 | -$2,720 |
| | 2025 | 2021 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R21NR017978 | The Social Context of Live Discharge from Hospice for Family Caregivers of Patients with Alzheimer's Disease and Related Dementias | 001 | 1 | NIH | 11/26/2024 | -$2,202 |
| | 2025 | 2020 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R15GM085699 | Understanding the Thermodynamics and Structure of RNA Secondary Structure Motifs | 000 | 4 | NIH | 12/19/2024 | -$16,880 |
| | 2025 | 2020 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01NS113257 | Isolation of GPR160 for biochemical analysis of the activation mechanism and development of a high throughput screening assay to identify small molecule inhibitors | 000 | 1 | NIH | 10/1/2024 | -$324,144 |
|
| Issue Date FY: 2024 ( Subtotal = $22,030,292 ) (Continued on the next page) |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | UM1AI148685 | Vaccine and Treatment Evaluation Unit at Saint Louis University | 002 | 5 | NIH | 6/11/2024 | $57,080 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | UM1AI148685 | Vaccine and Treatment Evaluation Unit at Saint Louis University | 001 | 5 | NIH | 12/6/2023 | $0 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | UM1AI148685 | Vaccine and Treatment Evaluation Unit at Saint Louis University | 001 | 5 | NIH | 12/6/2023 | $0 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | UM1AI148685 | Vaccine and Treatment Evaluation Unit at Saint Louis University | 000 | 5 | NIH | 11/15/2023 | $256,617 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | UM1AI148685 | Vaccine and Treatment Evaluation Unit at Saint Louis University | 000 | 5 | NIH | 11/15/2023 | $363,714 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01HL147821 | Structural enzymology of factor V activation | 002 | 6 | NIH | 6/13/2024 | $43,905 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | U13OH012639 | Translating research to practice in corrections staff mental health through dissemination of evidence: from pilots to practical programs | 00 | 1 | CDC | 9/17/2024 | $29,853 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R37CA265877 | Novel molecular mechanism for extracellular release of proteins implicated in metastatic cancer | 000 | 3 | NIH | 7/5/2024 | $394,314 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R15GM154275 | Characterizing the Function and Regulation of Ycx1, a New Member of the CCX Family of Exchangers | 000 | 1 | NIH | 9/3/2024 | $378,750 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R15GM155891 | Improving Artificial Intelligence Readiness of RNA Motif Data for Structure Analysis and Modeling | 000 | 1 | NIH | 9/19/2024 | $467,334 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R56AG064069 | Antisense Oligonucleotides for Progranulin-deficient Frontotemporal Dementia | 000 | 6 | NIH | 9/18/2024 | $75,350 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | S10OD036230 | High Q Technologies FATHOM Pulse EPR Spectrometer | 000 | 1 | NIH | 8/23/2024 | $1,746,529 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | S10OD036230 | High Q Technologies FATHOM Pulse EPR Spectrometer | 000 | 1 | NIH | 8/23/2024 | $1 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01NS114289 | Role of oligomeric TDP-43 aggregate intermediates in ALS and frontotemporal dementia | 001 | 5 | NIH | 7/11/2024 | $23,787 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01NS114289 | Role of oligomeric TDP-43 aggregate intermediates in ALS and frontotemporal dementia | 001 | 5 | NIH | 7/11/2024 | $11,363 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01NS114289 | Role of oligomeric TDP-43 aggregate intermediates in ALS and frontotemporal dementia | 001 | 5 | NIH | 7/11/2024 | $2,725 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01NS114289 | Role of oligomeric TDP-43 aggregate intermediates in ALS and frontotemporal dementia | 000 | 5 | NIH | 1/17/2024 | $320,875 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01NS114289 | Role of oligomeric TDP-43 aggregate intermediates in ALS and frontotemporal dementia | 000 | 5 | NIH | 1/17/2024 | $20,000 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R61NS138976 | Development of selective GPR34 antagonists for the treatment of neuropathic pain | 000 | 1 | NIH | 9/18/2024 | $1,511,970 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R03TR005223 | Conditional knock-in of Gnb3/Gngt2 in mouse rod photoreceptors | 000 | 1 | NIH | 7/24/2024 | $151,500 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R21AG088932 | Targeted Modulation of Longevity-Associated Genes Using Antisense Oligonucleotides | 000 | 1 | NIH | 8/5/2024 | $416,625 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R21AG089957 | Age, sex, hormonal status, and anti-inflammatory therapy for atherosclerosis | 000 | 1 | NIH | 7/18/2024 | $416,625 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | K23AR079035 | Neighborhood Barriers and Facilitators to Walking, the Epidemiology of Knee Osteoarthritis and Developing Effective Exercise Prescriptions | 000 | 3 | NIH | 1/25/2024 | $157,393 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | F30DK134124 | Defining Inflammatory Triggers that Induce Diverse Subtypes of Gastric Metaplasia | 001 | 2 | NIH | 4/29/2024 | $1,280 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | F30DK134124 | Defining Inflammatory Triggers that Induce Diverse Subtypes of Gastric Metaplasia | 000 | 2 | NIH | 12/7/2023 | $52,694 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R56HL169176 | ELECTROMECHANICAL COUPLING AND DISEASE MECHANISMS OF MYOCARDIAL CNBD FAMILY CHANNELS | 000 | 1 | NIH | 9/21/2024 | $620,371 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R35GM152125 | Methods and technologies for chemical synthesis of glycans | 000 | 1 | NIH | 1/26/2024 | $439,023 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R35GM154778 | VOLTAGE-SENSING MECHANISMS OF ION CHANNELS IN DYNAMIC LIPID MEMBRANES | 000 | 1 | NIH | 7/3/2024 | $378,750 |
|
